|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.120 USD | 0.00% |
|
-8.20% | -73.08% |
Company Valuation: Dogwood Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 42.61 | 4.326 | 11.07 | 3.317 | 123.7 | 38.07 | - | - |
| Change | - | -89.85% | 155.97% | -70.04% | 3,628.17% | -69.21% | - | - |
| Enterprise Value (EV) | 42.61 | 4.326 | 11.07 | 3.317 | 123.7 | 38.07 | 38.07 | 38.07 |
| Change | - | -89.85% | 155.97% | -70.04% | 3,628.17% | -69.21% | 0% | 0% |
| P/E | -2.66x | -0.21x | -2.05x | -0.2x | -0.58x | -1.28x | -1.76x | -1.74x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0x | -0x | 0x | 0x | 0.1x | -1.66x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 12.1x |
| EV / Revenue | - | - | - | - | - | - | - | 12.1x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.28x | -1.6x | -1.46x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -48 | -27.75 | -7 | -12.52 | -7.13 | -0.875 | -0.6367 | -0.6433 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 3.141 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -15.64 | -12.32 | -5.447 | -12.23 | -27.97 | -29.7 | -23.8 | -25.99 |
| Net income 1 | -15.96 | -12.25 | -5.296 | -12.86 | -35.51 | -29.57 | -23.82 | -26.01 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 127.875 | 5.900 | 14.375 | 2.490 | 4.160 | 1.120 | 1.120 | 1.120 |
| Nbr of stocks (in thousands) | 333 | 733 | 770 | 1,332 | 29,728 | 33,993 | - | - |
| Announcement Date | 3/17/22 | 3/14/23 | 2/29/24 | 3/14/25 | 3/18/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.28x | - | - | - | 38.07M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 8x | 26.2x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| Average | 23.97x | 26.46x | 15.68x | 0.32% | 38.32B | |
| Weighted average by Cap. | 26.72x | 25.33x | 15.90x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DWTX Stock
- Valuation Dogwood Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
